Mangalam Drugs & Organics Balance Sheet Health
Financial Health criteria checks 3/6
Mangalam Drugs & Organics has a total shareholder equity of ₹1.4B and total debt of ₹964.5M, which brings its debt-to-equity ratio to 71%. Its total assets and total liabilities are ₹3.3B and ₹2.0B respectively. Mangalam Drugs & Organics's EBIT is ₹27.5M making its interest coverage ratio 0.2. It has cash and short-term investments of ₹9.1M.
Key information
71.0%
Debt to equity ratio
₹964.49m
Debt
Interest coverage ratio | 0.2x |
Cash | ₹9.11m |
Equity | ₹1.36b |
Total liabilities | ₹1.98b |
Total assets | ₹3.33b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 532637's short term assets (₹1.8B) exceed its short term liabilities (₹1.6B).
Long Term Liabilities: 532637's short term assets (₹1.8B) exceed its long term liabilities (₹338.5M).
Debt to Equity History and Analysis
Debt Level: 532637's net debt to equity ratio (70.4%) is considered high.
Reducing Debt: 532637's debt to equity ratio has increased from 65.7% to 71% over the past 5 years.
Debt Coverage: 532637's debt is well covered by operating cash flow (41%).
Interest Coverage: 532637's interest payments on its debt are not well covered by EBIT (0.2x coverage).